High-throughput neural stem cell-based drug screening identifies S6K1 inhibition as a selective vulnerability in SHH-medulloblastoma
Preprint in bioRxiv (February 2024)
The most recent citing publications are shown below. View all 105 publications that cite this research output on Dimensions.
Preprint in bioRxiv (February 2024)
Article in World Neurosurgery (December 2023)
Book chapter (September 2023)